PlainRecalls
FDA Drug Moderate Class II Terminated

HYDROXO-B12 5ML PBF MDV 1MG/ML INJ, Injection, 1mg/ml, Rx only, packaged in 5 mL Glass/ Multiple Dose and 30 mL Glass/ Multiple Dose vials,Prepared by Key Compounding Pharmacy

Reported: May 24, 2017 Initiated: April 18, 2017 #D-0725-2017

Product Description

HYDROXO-B12 5ML PBF MDV 1MG/ML INJ, Injection, 1mg/ml, Rx only, packaged in 5 mL Glass/ Multiple Dose and 30 mL Glass/ Multiple Dose vials,Prepared by Key Compounding Pharmacy

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Details

Units Affected
7 vials total (1/5mL vial and 6/30 mL vials)
Distribution
Distributed nationwide in U.S.A., Australia and Canada.
Location
Federal Way, WA

Frequently Asked Questions

What product was recalled?
HYDROXO-B12 5ML PBF MDV 1MG/ML INJ, Injection, 1mg/ml, Rx only, packaged in 5 mL Glass/ Multiple Dose and 30 mL Glass/ Multiple Dose vials,Prepared by Key Compounding Pharmacy. Recalled by Key Pharmacy and Compounding Center. Units affected: 7 vials total (1/5mL vial and 6/30 mL vials).
Why was this product recalled?
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 24, 2017. Severity: Moderate. Recall number: D-0725-2017.